EQT Logo
Current Portfolio

XyloCor Therapeutics

US biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease.

Key Facts
Sector

Life Sciences

Country

United States

Fund

LSP 6

Entry

2018

A 3D rendering of a blue, spiky virus-like structure with protruding rods.

Do You Want to Know More?

We are eager to explore how we can achieve great things together.